Supportive Oligonucleotide Therapy (SOT) is an experimental treatment that uses custom-built genetic sequences to block the replication of specific pathogens, such as Lyme disease, Epstein-Barr virus, and cancer cells. Because it targets the exact genes bacteria or viruses use to reproduce, it operates differently than traditional systemic drugs. [1, 2, 3, 4, 5]
Common SOT Combinations
- Oncological Support: For cancer treatments, SOT (Synergistic Oncology Therapy) has been used alongside low-dose insulin potentiated chemotherapy (IPT) or homeopathic support to target tumor cells while sparing healthy tissue. [1]
The SOT Process
Further Exploration
- Read an overview of the therapy from LymeDisease.org.
- Explore a comparison between SOT and traditional cancer treatments on Forsythe Cancer Care Center.